26,000 volunteers participating for phase 3 trials for Covaxin vaccine


Bharat Bitoech International Ltd. stated on Monday that there will be an increase in the number of clinical trials for its COVID-19 vaccine ‘Covaxin’. The company will be only allowing participation  of 26,000 volunteers at 25 different trials sites from all over India in next few months.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More